Market Insight - Fear gives way to prudence as VCs eye return of bull biotech market
19 February 2010
Ian Schofield
Please Login to read the full article.
19 February 2010
Ian Schofield
ian.schofield@informa.com
2009 was a bad year for investment in the biotech sector, with venture capital funds fleeing to safer havens and many small firms struggling to get enough financing to keep their R&D projects afloat. Opinions vary as to how far the economic recovery will revive biotech's fortunes this year, but many...
Please Login to read the full article.
RELATED CONTENT
NEWS
- Scotland boosts bioincubator space to bolster life science sector
- Roche pays $30 million up front for preclinical rare disease programme
- Amira asset DP2 blockers spun out, not part of BMS $325 million buyout
- Senator looks to 80/20 mantra to save PDUFA V in rancorous congressional climate
FEATURES
Other Informa Features
EVENTS
26 February 2012
Vancouver Convention Centre | Vancouver, BC, Canada
28 February 2012
Pestana Chelsea Bridge Hotel London
04 March 2012
The Marriott World Center, Orlando, Florida
JOB OF THE WEEK
Promote your vacancy here
